SCOPUS 정보 검색 플랫폼

Investigational New Drugs

Volumn 18, Issue 4, 2000, Pages 355-363

Capecitabine

(1) Budman, Daniel R a

a NORTH SHORE UNIVERSITY HOSPITAL (United States)

Author keywords

Capecitabine; Enzymatic activation; Prodrug

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; 5 ETHYNYLURACIL; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CAPECITABINE; DOCETAXEL; DOXIFLURIDINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; PACLITAXEL; UFT;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; GASTROINTESTINAL TOXICITY; HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TREATMENT OUTCOME;

ANIMAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; FLUOROURACIL; HUMAN; PRODRUGS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033770114 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1006449315650 Document Type: Review

Times cited : (39)

References (38)

1
- 0031611753
- Computer-assisted design of new drags based upon retrometabolic concepts
- (1998) SAR QSAR Environ Res , vol.8 , pp. 41-92
- Bodor, N.¹ Buchwald, P.² Huang, M.³

2
- 33745464490
- Fluorinated pyrimidines: A new class of tumor-inhibitory compounds
- (1957) Nature , vol.179 , pp. 663-666
- Heidelberger, C.¹

3
- 0033045023
- High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusion
- (1999) Clin Cancer Res , vol.5 , pp. 1347-1352
- Takimoto, C.¹ Yee, L.² Venzon, D.³ Schuler, B.⁴ Grollman, F.⁵ Chabuk, C.⁶ Hamilton, J.⁷ Chen, A.⁸ Allegra, C.⁹ Grem, J.¹⁰

4
- 0018576207
- Fluorinated pyrimidine nucleotides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropymidine nucleotides
- (1979) J Med Chem , vol.22 , pp. 1330-1335
- Cook, A.¹ Holman, M.² Krammer, M.³ Trown, P.⁴

5
- 0018821981
- Role of uridine phosphorylase for antitumor activity of 5'-deoxy-S-fluorouridine
- (1980) Gann , vol.71 , pp. 112-123
- Ishitsuka, H.¹ Miwa, M.² Takemoto, K.³ Fukuoka, K.⁴ Itoga, A.⁵ Maruyama, H.⁶

6
- 0018868261
- Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine
- (1980) Eur J Cancer , vol.16 , pp. 427-432
- Bollag, W.¹ Hartmann, H.²

7
- 0018899298
- Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor bearing mice and rats
- (1980) Gann , vol.71 , pp. 238-245
- Suzuki, S.¹ Hongu, Y.² Fukazawa, H.³ Ichihara, S.⁴ Shimizu, H.⁵

8
- 0028360756
- Remarkable antitumor activity of 5'-deoxy-5-fluorouridine in human colorectal xenografts
- (1994) AntiCancer Res , vol.14 , pp. 549-554
- De Cesare, M.¹ Pratesi, G.² De Braud, F.³ Zuninno, F.⁴ Stampino, C.⁵

9
- 0029037859
- Selective inhibition of spontaneous pulmonary metastasis of Lewis lung carcinoma by 5'-deoxy-5-fluorouridine
- (1995) Int J Cancer , vol.61 , pp. 516-521
- Ishikawa, T.¹ Ura, M.² Yamamoto, T.³ Tanaka, Y.⁴ Ishitsuka, H.⁵

10
- 0028177390
- Y-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expression
- (1994) Jpn J Cancer Res , vol.85 , pp. 13-16
- Van der Heyden, S.¹ Gheuens, E.² Van de Vrie, W.³ Van Bockstaele, D.⁴ Van Oosterom, A.⁵ Eggermont, A.⁶ De Bruijn, E.A.⁷

11
- 4243877467
- A phase III study comparing oral 5'-deoxy-5-fluorouridine and oral 5-fluorouracil in patients with curative gastric cancer (Meeting Abstract)
- (1999) Proc Annu Meet Am Soc Clin Oncol , vol.18
- Takiguchi, N.¹ Nakajima, N.² Saitoh, N.³ FuJimoto, S.⁴ Nakazato, H.⁵

12
- 0002323675
- Perry M (ed): The Chemotherapy Sourcebook (ed 2). Baltimore, Williams and Wilkins
- (1996) Investigational Drugs , pp. 479-558
- Budman, D.¹ Lichtman, S.²

13
- 0028803424
- Metastatic colorectal cancer: Advances in biochemical modulation and new drug development
- (1995) Semin Oncol , vol.22 , pp. 509-524
- Meropol, N.¹ Creaven, P.² Petrelli, N.³

14
- 0025326020
- Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouradine and its prodrug trimethoxybenzoyl-5'-deoxyflourocytidine
- (1990) Jpn Cancer Res , vol.81 , pp. 188-195
- Ninomlya, Y.¹ Miwa, M.² Eda, H.³

15
- 0032127244
- Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
- (1998) Eur J Cancer , vol.34 , pp. 1274-1281
- Miwa, M.¹ Ura, M.² Nishida, M.³ Sawada, N.⁴ Ishikawa, T.⁵ Mori, K.⁶ Shimma, N.⁷ Umeda, I.⁸ Ishitsuka, H.⁹

16
- 0030027519
- The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
- (1996) Br J Cancer , vol.73 , pp. 275-280
- Fox, S.B.¹ Westwood, M.² Moghaddam, A.³ Comley, M.⁴ Turley, H.⁵ Whitehouse, R.M.⁶ Bicknell, R.⁷ Gatter, K.C.⁸ Harris, A.L.⁹

17
- 0344541873
- Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbarnate, in human cancer xenografts
- (1998) Bio Chem Pharmacol , vol.55 , pp. 1091-1097
- Ishikawa, T.¹ Utoh, M.² Sawada, N.³ Nishida, M.⁴ Fukase, Y.⁵ Sekiguchi, F.⁶ Ishitsuka, H.⁷

18
- 0000092361
- Antitumor efficacy of capecitabine against fluorouracil-sensitive and -resistant tumors (Meeting Abstract)
- (1997) Proc Annu Meet Am Soc Clin Oncol , vol.16
- Cao, S.¹ Lu, K.² Ishitsuka, H.³ Rusturn, Y.M.⁴

19
- 0032520168
- Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts
- (1998) Cancer Res , vol.58 , pp. 685-690
- Ishikawa, T.¹ Sekiguchi, F.² Fukase, Y.³ Sawada, N.⁴ Ishitsuka, H.⁵

20
- 0032924707
- Prediction of response to 5'-deoxy-5-fluorouridine (5'DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor
- (1999) Oncology , vol.56 , pp. 215-222
- Koizumi, W.¹ Saigenji, K.² Nakamaru, N.³ Okayasu, I.⁴ Kurihara, M.⁵

21
- 0031944611
- Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts
- (1998) Clin Cancer Res , vol.4 , pp. 1013-1019
- Sawada, N.¹ Ishikawa, T.² Fukase, Y.³ Nishida, M.⁴ Yoshikubo, T.⁵ Ishitsuka, H.⁶

22
- 0007522090
- Capecitabine and the dThdPase upregulators IFNgamma or Taxol showed synergistic activity in human cancer xenografts (Meeting abstract)
- (1996) Proc Annu Meet Am Assoc Cancer Res , vol.37
- Ishitsuka, H.¹ Ishikawa, T.² Fukase, Y.³ Sawada, N.⁴ Tanaka, Y.⁵ Ouchi, K.⁶ Yoshikubo, T.⁷ Nishida, M.⁸

23
- 0030993629
- Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo
- (1997) Clin Cancer Res , vol.3 , pp. 923-929
- Makower, D.¹ Wadler, S.² Haynes, H.³ Schwartz, E.L.⁴

24
- 0027313603
- Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine
- (1993) Cancer Chemother Pharmacol , vol.32 , pp. 333-338
- Eda, H.¹ FuJimoto, K.² Watanabe, S.³ Ura, M.⁴ Hino, A.⁵ Tanaka, Y.⁶ Wada, K.⁷ Ishitsuka, H.⁸

25
- 0031859855
- Preliminary studies of a novel oral fluoropyrimidine carbamate: Capecitabine
- (1998) J Clin Oncol , vol.16 , pp. 1795-1802
- Budman, D.R.¹ Meropol, N.J.² Reigner, B.³ Creaven, P.J.⁴ Lichtnian, S.M.⁵ Berghorn, E.⁶ Behr, J.⁷ Gordon, R.J.⁸ Osterwaider, B.⁹ Griffin, T.¹⁰

26
- 0031671094
- Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer
- (1998) J Clin Oncol , vol.16 , pp. 2977-2985
- Mackean, M.¹ Planting, A.² Twelves, C.³ Schellens, J.⁴ Allman, D.⁵ Osterwalder, B.⁶ Reigner, B.⁷ Griffin, T.⁸ Kaye, S.⁹ Verweij, J.¹⁰

27
- 0031724433
- A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors
- (1998) Clin Cancer Res , vol.4 , pp. 2755-2761
- Cassidy, J.¹ Dirix, L.² Bissett, D.³ Reigner, B.⁴ Griffin, T.⁵ Allman, D.⁶ Osterwalder, B.⁷ Van Oosterom, A.T.⁸

28
- 0030477466
- A pilot safety study of capecitabine, a new oral fluoropyrimidine, in patients with advanced neoplastic disease
- (1996) Tumori , vol.82 , pp. 450-452
- Bajetta, E.¹ Carnaghi, C.² Somma, L.³ Stampino, C.G.⁴

29
- 0033040540
- Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies
- (1999) J Clin Oncol , vol.17 , pp. 1915-1925
- Villalona-Calero, M.¹ Weiss, G.² Burris, H.³ Kraynak, M.⁴ Rodriques, G.⁵ Drengler, R.⁶ Eckhardt, S.⁷ Reigner, B.⁸ Maczygemba, J.⁹ Burger, H.¹⁰ Griffin, T.¹¹ Von Hoff, D.¹² Rowinsky, E.¹³

30
- 4243797065
- Phase I trial of capecitabine and subcutaneous interferon-alpha in renal cell carcinoma (Meeting Abstract)
- (1999) Proc Annu Meet Am Soc Clin Oncol , vol.18
- Olencki, T.¹ Pratt, S.² Budd, G.³ Peereboom, D.⁴ McClain, D.⁵ Bukowski, R.⁶

31
- 0027787736
- Workman P, Graham M (eds): Cancer Surveys, Pharmacokinetics and Cancer Chemotherapy. Cold Spring Harbor, Cold Spring Harbor Laboratory Press
- (1993) New approaches in preclinical and cancer pharmacokinetics , pp. 27-49
- Graham, M.¹ Kaye, S.²

32
- 4243877545
- Hepatic dysfunction due to liver metastasis does not affect the bioactivation of Xeloda (Meeting Abstract)
- (1998) Proc Annu Meet Am Soc Clin Oncol , vol.17
- Reigner, B.¹ Jones, R.² Cassidy, J.³ Schuller, J.⁴ Goggin, T.⁵ Jones, D.⁶ Twelves, C.⁷

33
- 0032979671
- Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients
- (1999) Cancer Chemother Pharmacol , vol.43 , pp. 309-315
- Reigner, B.¹ Clive, S.² Cassidy, J.³ Jodrell, D.⁴ Schulz, R.⁵ Goggin, T.⁶ Banken, L.⁷ Roos, B.⁸ Utoh, M.⁹ Mulligan, T.¹⁰ Weidekamm, E.¹¹

34
- 14444280873
- Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients
- (1998) Clin Cancer Res , vol.4 , pp. 941-948
- Reigner, B.¹ Verweij, J.² Dirix, L.³ Cassidy, J.⁴ Twelves, C.⁵ Allman, D.⁶ Weidekamm, E.⁷ Roos, B.⁸ Banken, L.⁹ Utoh, M.¹⁰ Osterwalder, B.¹¹

35
- 0000447472
- Tumor selectivity of Xeloda in colorectal cancer patients (Meeting abstract)
- (1998) Proc Annu Meet Am Soc Clin Oncol
- Schuller, J.¹ Cassidy, J.² Reigner, G.³ Durston, S.⁴ Roos, B.⁵ Ishitsuka, H.⁶ Utoh, M.⁷ Dumont, E.⁸

36
- 0033050165
- Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
- (1999) J Clin Oncol , vol.17 , pp. 485-493
- Blum, J.L.¹ Jones, S.E.² Buzdar, A.U.³ LoRusso, P.M.⁴ Ktiter, I.⁵ Vogel, C.⁶ Osterwalder, B.⁷ Burger, H.U.⁸ Brown, C.S.⁹ Griffin, T.¹⁰

37
- 0033091602
- [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine]
- (1999) Gan , vol.26 , pp. 447-455
- Saeki, T.¹ Takashima, S.²

38
- 0000344523
- A randomized phase II study of Xeloda (capecitabine) in patients with advanced colorectal cancer (Meeting abstract)
- (1997) Proc Annu Meet Am Soc Clin Oncol
- Findlay, M.¹ Van Cutsem, E.² Kocha, W.³ Allman, D.⁴ Laffranchi, B.⁵ Griffin, T.⁶ Osterwalder, B.⁷ Dalley, D.⁸ Pazdur, R.⁹ Verweij, J.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.